High weekly doses of liposomal amphotericin B as secondary prophylaxis after cerebral aspergillosis in a paediatric patient

Medical Mycology Case Reports

Volumn 3, Issue 1, 2014, Pages 1-3

  Brazzola, Pierluigi ^a   Rossi, Mario R ^a  

^a Pediatria ^*  (Switzerland)

Author keywords

Aspergillosis; Aspergillus fumigatus; Invasive fungal infection; Liposomal amphotericin B; Voriconazole

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN ABSCESS; BRAIN DAMAGE; BRAIN VENTRICULITIS; CASE REPORT; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CEREBROSPINAL FLUID LEVEL; CHILD; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE HYDROCEPHALUS; PRESCHOOL CHILD; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME; SYNDROME;

EID: 84890397542     PISSN: 22117539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mmcr.2013.10.003     Document Type: Article

References (19)

1. S. Gallien, S. Fournier, R. Porcher, J. Bottero, P. Ribaud, and A. Sulahian Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases Infection 36 6 2008 533 538
2. A. McCormick, J. Loeffler, and F. Ebel Aspergillus fumigatus: contours of an opportunistic human pathogen Cell Microbiol 12 11 2010 1535 1543
3. L. Cahuayme-Zuniga, R.E. Lewis, V.E. Mulanovich, and D.P. Kontoyiannis Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies Med Mycol: Off Publ Int Soc Hum Anim Mycol 50 5 2012 543 548
4. T.J. Walsh, I. Raad, T.F. Patterson, P. Chandrasekar, G.R. Donowitz, and R. Graybill Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial Clin Infect Dis 44 1 2007 2 12
5. T.J. Walsh, I. Lutsar, T. Driscoll, B. Dupont, M. Roden, and P. Ghahramani Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children Pediatr Infect Dis J 21 3 2002 240 248
6. C. Gubler, S.M. Wildi, A. Imhof, M. Schneemann, and B. Mullhaupt Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole Infection 35 5 2007 364 366
7. G. Krivan, J. Sinko, I.Z. Nagy, V. Goda, P. Remenyi, and A. Batai Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation Acta Biomed: Atenei Parm 77 Suppl. 2 2006 17 21
8. J. Maertens, I. Raad, G. Petrikkos, M. Boogaerts, D. Selleslag, and F.B. Petersen Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy Clin Infect Dis 39 11 2004 1563 1571
9. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 3 2008 327 360
10. M. Karthaus Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature Eur J Med Res 16 4 2011 145 152
11. L. Mele, L. Pagano, F. Equitani, and G. Leone Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy Mycoses 44 5 2001 201 203
12. T. Flohr, A. Schrauder, G. Cazzaniga, R. Panzer-Grumayer, V. van der Velden, and S. Fischer Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia Leukemia 22 4 2008 771 782
13. G. Eschenauer, D.D. DePestel, and P.L. Carver Comparison of echinocandin antifungals Ther Clin Risk Manag 3 1 2007 71 97
14. A. Ng, N. Gadong, A. Kelsey, D.W. Denning, J. Leggate, and O.B. Eden Successful treatment of Aspergillus brain abscess in a child with acute lymphoblastic leukemia Pediatr Hematol Oncol 17 6 2000 497 504
15. S. Pradhan, and R. Yadav Invasive aspergillosis of the brain: improvement with lyposomal amphotericin B and itraconazole Neurol India 55 3 2007 309 310
16. G. Prakash, S. Thulkar, S.K. Arava, and S. Bakhshi Cerebral Aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy Indian J Med Paediatr Oncol: Off J Indian Soc Med Paediatr Oncol 33 4 2012 236 238
17. A.H. Groll, N. Giri, V. Petraitis, R. Petraitiene, M. Candelario, and J.S. Bacher Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system J Infect Dis 182 1 2000 274 282
18. S. Kethireddy, and D. Andes CNS pharmacokinetics of antifungal agents Expert Opin Drug Metab Toxicol 3 4 2007 573 581
19. P.O. Gubbins, J.R. Amsden, S.A. McConnell, and E.J. Anaissie Pharmacokinetics and buccal mucosal concentrations of a 15 mg per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cell transplant patients Antimicrob Agents Chemother 53 9 2009 3664 3674